Cusyn 500 mg POWDER FOR SOLUTION FOR INFUSION
PDF Leaflet Revision Date: 23 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for complicated skin infections and Staphylococcus aureus bloodstream infections.
Dosage (summary)
cSSSI: 4 mg/kg IV daily; SAB/RIE: 6 mg/kg IV daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- Increased risk of myopathy with statins
- False PT/INR prolongation with certain assays
Contraindications
- Hypersensitivity to daptomycin
- Treatment of pneumonia
Common side effects
- Dizziness
- Nausea
- Rash
- Increased CPK
- Infusion site reactions
Counselling Points
- Monitor for muscle pain and CPK levels
- Avoid driving if dizzy
- Report any allergic reactions immediately
Serious warnings
- Risk of myopathy
- Eosinophilic pneumonia
- Severe cutaneous adverse reactions
Important Disclaimer
The Cusyn 500 mg POWDER FOR SOLUTION FOR INFUSION professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
